Synthetic malaria peptide vaccine elicits high levels of antibodies in vaccinees of defined HLA genotypes.

Saved in:
Bibliographic Details
Title: Synthetic malaria peptide vaccine elicits high levels of antibodies in vaccinees of defined HLA genotypes.
Authors: Nardin EH; New York University School of Medicine, Dept. of Medical and Molecular Parasitology, New York, NY 10010, USA. Elizabeth.Nardin@med.nyu.edu, Oliveira GA, Calvo-Calle JM, Castro ZR, Nussenzweig RS, Schmeckpeper B, Hall BF, Diggs C, Bodison S, Edelman R
Source: The Journal of infectious diseases [J Infect Dis] 2000 Nov; Vol. 182 (5), pp. 1486-96. Date of Electronic Publication: 2000 Oct 09.
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0022-1899 (Print) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:0022-1899
DOI:10.1086/315871